Qube Research & Technologies (QRT)
ETON icon

Qube Research & Technologies (QRT)’s Eton Pharmaceutcials ETON Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.01M Buy
+155,654
New +$7.9M 0.01% 1572
2025
Q3 		– Sell
-34,557
Closed -$492K – 3687
2025
Q2 		$492K Sell
34,557
-52,291
-60% -$827K ﹤0.01% 2700
2025
Q1 		$1.13M Sell
86,848
-7,333
-8% -$111K ﹤0.01% 2204
2024
Q4 		$1.25M Buy
94,181
+61,839
+191% +$627K ﹤0.01% 2078
2024
Q3 		$194K Buy
32,342
+32,338
+808,450% +$137K ﹤0.01% 2594
2024
Q2 		$14 Sell
4
-44,610
-100% -$156K ﹤0.01% 3596
2024
Q1 		$167K Sell
44,614
-5,829
-12% -$25.5K ﹤0.01% 3106
2023
Q4 		$221K Buy
50,443
+45,686
+960% +$183K ﹤0.01% 2735
2023
Q3 		$19.8K Buy
+4,757
New +$18.4K ﹤0.01% 3148

Other funds holding ETON

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
National Philanthropic Trust
National Philanthropic Trust Jenkintown, Pennsylvania $7.05B AUM 11.49% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ETON Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Eton Pharmaceutcials (ETON) in Q3 2026: 155,654 shares worth $8.01M. The stake represents 0.01% of the portfolio and ranks #1572 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ETON as recently as Q2 2025.

Qube Research & Technologies (QRT) first reported a position in ETON in Q3 2023 and has held it in 9 quarters since. 162 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • Qube Research & Technologies (QRT) held 155,654 shares of Eton Pharmaceutcials worth $8.01M as of Q3 2026.
  • Eton Pharmaceutcials was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • Eton Pharmaceutcials made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1572 holding.
  • Qube Research & Technologies (QRT) first reported a position in Eton Pharmaceutcials in Q3 2023 and has held it in 9 quarters since.
  • 162 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.